Pranlukast Attenuates Hydrogen Peroxide–induced Necrosis in Endothelial Cells by Inhibiting Oxygen Reactive Species–mediated Collapse of Mitochondrial Membrane Potential
- 1 April 2011
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Cardiovascular Pharmacology
- Vol. 57 (4), 479-488
- https://doi.org/10.1097/fjc.0b013e31821076d3
Abstract
Recently, we reported that pranlukast, an antagonist of cysteinyl leukotriene receptor 1, attenuates ischemic injury in endothelial cells by decreasing reactive oxygen species (ROS) production and inhibiting nuclear factor-κB activation in a leukotriene-independent manner. In this study, we investigated the effect of pranlukast on oxidative stress injury induced by hydrogen peroxide (H2O2) in EA.hy926 cells, a human endothelial cell line, and the possible mechanisms. We found that H2O2 reduced cell viability and increased lactate dehydrogenase release in a concentration- and time-dependent manner. Necrosis was the main death mode, and the necrotic rate increased 32% after exposure to 220 μM H2O2 for 4 hours. Pretreatment with pranlukast significantly ameliorated the reduced viability and the increased lactate dehydrogenase release and necrosis after exposure to H2O2. We next examined the mechanisms underlying the antinecrotic effects of pranlukast. The results showed that pranlukast attenuated excessive ROS production and ameliorated the reduced superoxide dismuase and glutathione peroxidase activity in EA.hy926 cells exposed to H2O2. Pranlukast also inhibited the collapse of mitochondrial membrane potential (MMP) induced by H2O2. Inhibition of ROS production by N-acetyl-l-cysteine, a powerful antioxidant, reduced MMP collapse and necrosis. Inhibition of MMP collapse by cyclosporine A, a mitochondrial permeability transition inhibitor, attenuated necrosis but failed to reduce ROS production. In addition, we found no expression of 5-lipoxygenase in EA.hy926 cells and zileuton, a 5-lipoxygenase inhibitor, did not affect the cellular injury induced by H2O2. Pranlukast protects endothelial cells from H2O2-induced necrosis by inhibiting ROS-mediated collapse of mitochondrial membrane potential, and this is leukotriene-independent.Keywords
This publication has 40 references indexed in Scilit:
- l‐Glutamine‐induced apoptosis in microglia is mediated by mitochondrial dysfunctionEuropean Journal of Neuroscience, 2009
- Contribution of a mitochondrial pathway to excitotoxic neuronal necrosisJournal of Neuroscience Research, 2009
- Neuroprotective strategies targeting apoptotic and necrotic cell death for strokeApoptosis, 2009
- Pranlukast Attenuates Ischemia-like Injury in Endothelial Cells Via Inhibiting Reactive Oxygen Species Production and Nuclear Factor-κB ActivationJournal of Cardiovascular Pharmacology, 2009
- NADPH Oxidase Plays a Central Role in Blood-Brain Barrier Damage in Experimental StrokeStroke, 2007
- Expression of 5‐lipoxygenase (5‐LOX) in T lymphocytesImmunology, 2007
- Exercise and HormesisAnnals of the New York Academy of Sciences, 2006
- Mitochondrial permeability transition in apoptosis and necrosisCell Death & Differentiation, 2005
- The selection between apoptosis and necrosis is differentially regulated in hydrogen peroxide-treated and glutathione-depleted human promonocytic cellsCell Death & Differentiation, 2003
- A permanent human cell line (EA.hy926) preserves the characteristics of endothelin converting enzyme from primary human umbilical vein endothelial cellsLife Sciences, 1995